A zero you can’t verify is your riskiest result.

From automated colony counting and plate sorting to digital review and sample traceability, Reshape brings greater consistency, efficiency, and confidence to pharmaceutical environmental monitoring.

  • Mascoma, a Lallemand company
  • Imperial College London
  • University of Oxford
  • Aviagen
  • Stepan
  • Syngenta

The problem

A negative result still needs evidence.

<1%

of Grade A plates should show any growth. 0 CFU is the limit – anything above it is investigated.

[Source: EU GMP Annex 1 (2022) · USP <1116> – confirm citation]

50%

difference between operators, across 13,000+ plates. Most miscounts were colonies of 53–63 µm – the smallest on the plate.

[Source: 13,000+ plate operator study – confirm citation]

1,400–4,300

reading hours a year at 10,000 plates a month. Every empty plate still costs a microbiologist’s time – often twice.

[Source: read-time basis for 10,000 plates/month – confirm citation]

Plate images sorted by result in the Reshape platform: needs validation, positive, negative and error

FDA has found growth recorded as zero – more than once.

  1. Growth not identified
  2. Growth recorded as “Nil”
  3. Uncountable plate logged as zero
  4. Growth plates swapped for clean

You cannot review a plate that was never recorded.

FDA warning letters, 2011–2026. Sites not named.

An image behind every result – for QA, trending and investigations

The plate image is the original record. It stays with the count, the reader and the time so a questioned result can be reviewed instead of re-argued.

Reshape your workflow with high throughput testing & zero hassle

High precision tech designed to process 700 plates per hour

  1. 01 Pre-analytical

    Sample tracking

    Track Every Sample

    Link samples to barcodes and relevant metadata, creating a traceable record before analysis begins.

  2. 02 Analytical

    AI-powered analysis

    Automate Plate Reading

    Capture and analyze microbial culture plates with standardized AI models and automatically flag results for review.

  3. 03 Post-analytical

    Digital traceability

    Review with Confidence

    Access images, results, and activity history.

Reshape High Throughput Imaging Device with stacked culture plates in its loading towers and the touchscreen showing a run in progress

Support in labs through Grade A → D

An image behind every result – for QC, QA, trending and investigations.

The plate image is the original record. It stays with the count, the reader and the time, so a questioned result can be reviewed instead of re-argued.

  • ALCOA+

    Image kept as the record

  • 21 CFR Part 11

    Designed to support 21 CFR Part 11 audit trail and secure records

  • EU GMP Annex 1 · [§ ref]

    QA oversight of every result, including remote review

  • EU GMP Annex 1 · [§ ref]

    Digital records that make trending easy

  • EU GMP Annex 1 · [§ ref]

    Patterns visible for investigations

  • EU GMP Annex 1 · Table 6

    Reported in CFU

Certifications and frameworks

  • SOC 2 Type II
  • ISO 27001
  • 21 CFR Part 11
  • ISO 17025
  • GAMP 5

Qualification

Qualified under cGMP in five signed records.

The model is tuned on your own plates first. PQ tests it against your analysts to criteria agreed up front.

  1. 01PlanApproved first
  2. 02Workspace IQ/OQ1–2 days
  3. 03Device IQ/OQ1–2 days
  4. 04PQ per method4–6 weeks, against your analysts
  5. 05Analysis OQ/PQ1–2 days

Want a closer look at how Reshape supports standardized QC testing workflows?

Discuss Your QC Workflow →

Reshape for Pharma QC

Book a demo

See automated plate reading, sorting and digital review running on plates like yours.

I’d like to

We use your details only to respond to this request.